|
 |
 |
| |
| SPIbio has at your disposal research and development high experienced personnel which have been teaming up over fifteen years with pharmaceutical laboratories. The skilled and multidisciplinary teams are from three departments of the CEA, which are: | |  |
|
| |
 | The Frédéric Joliot Hospital Department (SHFJ) |
|
| |
| Since 1958, the Frédéric Joliot Hospital, has been developing number of techniques allowing the functional study of organs in man. This centre of excellence in the fields of the use of isotope markers in man places at the disposal of pharmaceutical companies its unique equipement. This Clinical Pharmacology Unit conducts studies to demonstrate the mode of action of drugs on their targets such as membrane (central nervous system, cardiovascular system) or to study the pharmacological effect of drugs on metabolic process (cerebral blood flow, regional tissue oxygen consumption). |
| |
|
| |
| The Pharmacology and Immunology Department (SPI) |
|
| |
| Over 15 years, the SPI has been studying pharmacokinetics and metabolism of xenobiotics and development, validation of assays & drug measurement (HPLC, GC, GC/MS, HPLC/MS/MS, RIA, EIA). The variety of methodological approaches and multidisciplinarity of our teams are at your disposal for the: |
| |
- Development and validation of assays and biological sample analysis;
- Human and animal pharmacokinetics and metabolism of your molecule.
|
| |
|
| |
| The NeuroVirology Department (SNV) |
|
| |
| The SNV has its own scientific and medical expertise for therapies such as HIV infection, Parkinson, scelorisis, Alzheimer, growth deficiencies. In addition, our high qualified and experimented teams are also experts in the evaluation of antiretroviral and immunomodulatory drugs, in microbiolgical safety of purification and manufacturing processes and evaluation of disinfectant molecules. |
| |
